Detalhe da pesquisa
1.
Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy.
Int J Cancer
; 154(12): 2142-2150, 2024 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38447003
2.
Differential Effects of Somatostatin, Octreotide, and Lanreotide on Neuroendocrine Differentiation and Proliferation in Established and Primary NET Cell Lines: Possible Crosstalk with TGF-ß Signaling.
Int J Mol Sci
; 23(24)2022 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36555512
3.
Tailored Systemic Therapy for Colorectal Cancer Liver Metastases.
Int J Mol Sci
; 22(21)2021 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34769209
4.
Phase III randomized, double-blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC).
Int J Cancer
; 147(9): 2493-2502, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32339253
5.
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.
Lancet
; 393(10184): 1948-1957, 2019 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30982686
6.
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial.
Lancet Oncol
; 17(12): 1697-1708, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27776843
7.
Comprehensive biomarker analysis of long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinoma.
Eur J Cancer
; 183: 119-130, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36848831
8.
Pathological complete remission in patients with oesophagogastric cancer receiving preoperative 5-fluorouracil, oxaliplatin and docetaxel.
Int J Cancer
; 130(7): 1706-13, 2012 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21618509
9.
Local calprotectin production in colorectal cancer and polyps--active neutrophil recruitment in carcinogenesis.
Int J Colorectal Dis
; 26(5): 603-7, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21380506
10.
Resection of Non-Functional Pancreatic Neuroendocrine Neoplasms-A Single-Center Retrospective Outcome Analysis.
Curr Oncol
; 28(4): 3071-3080, 2021 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34436034
11.
A Comprehensive Molecular Characterization of the Pancreatic Neuroendocrine Tumor Cell Lines BON-1 and QGP-1.
Cancers (Basel)
; 12(3)2020 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32183367
12.
MicroRNA analysis of gastroenteropancreatic neuroendocrine tumors and metastases.
Oncotarget
; 9(47): 28379-28390, 2018 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29983867
13.
Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial.
JAMA Oncol
; 3(9): 1237-1244, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28448662
14.
The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: a randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+).
Eur J Cancer
; 49(4): 835-42, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23063354
15.
Single nucleotide polymorphisms in TP53 but not KRAS or MDM2 are predictive of clinical outcome in multiple myeloma treated with high-dose melphalan and autologous stem cell support.
Leuk Lymphoma
; 57(6): 1482-6, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26414189
16.
Favorable prognostic impact of RAS mutation status in multiple myeloma treated with high-dose melphalan and autologous stem cell support in the era of novel agents: a single center perspective.
Leuk Lymphoma
; 57(1): 226-9, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-25947035
17.
[Idiopathic thrombocytopenic purpura (Werlhof disease) and differential diagnosis from other thrombocytopenic hemorrhagic diatheses]. / Idiopathische thrombozytopenische Purpura (Morbus Werlhof) und ihre Abgrenzung von anderen thrombozytopenischen hämorrhagischen Diathesen.
Med Klin (Munich)
; 104(5): 372-83, 2009 May 15.
Artigo
em Alemão
| MEDLINE | ID: mdl-19444418